Pressure Ulcer Devices Market Size, Share, Trends and Forecast, 2026–2035

Pressure Ulcer Devices Market Size and Forecast

The global pressure ulcer devices market reached USD 4.39 billion in 2025 and is forecast to reach USD 8.47 billion by 2035, advancing at a 6.8% CAGR from 2026 to 2035. 

Pressure ulcer devices cover products used to prevent, detect or manage pressure injuries caused by sustained pressure, shear, friction and adverse skin microclimate. The commercial scope includes pressure-relief mattresses, specialty beds, pressure-relief cushions, alternating-pressure wheelchair cushions, positioning accessories, advanced wound dressings and related systems. The market therefore spans durable equipment, single-patient consumables and connected monitoring rather than a single product class.

The purchasing trigger is shifting from equipment replacement to measurable prevention. In the United States, the Agency for Healthcare Research and Quality reports that more than 2.5 million people develop pressure ulcers each year. CMS also applies a 1% Medicare payment reduction to hospitals in the worst-performing quartile of its Hospital-Acquired Condition Reduction Program. These policies strengthen demand for products that document patient turning, redistribute pressure, control moisture and reduce avoidable treatment episodes.

Pressure Ulcer Devices Market Key Highlights

• 2025 market size: US$4.11 billion
• 2035 projected market size: US$7.93 billion
• Forecast CAGR, 2026–2035: 6.8%
• Largest product segment: Pressure relief mattresses, 30.81% share in 2025
• Largest region: North America, 42.17% share in 2025
• Fastest-growing region: Asia-Pacific, reported CAGR of 8.7%
• Fastest-growing product segment: Alternating pressure wheelchair cushions, reported 15.76% share in 2025
• Key players: Stryker, Baxter (Hillrom), 3M, Arjo, Mölnlycke Health Care, ConvaTec, Coloplast and Smith+Nephew

Market Definition and Scope

The report includes therapeutic support surfaces, specialty beds with pressure-management functions, powered and non-powered mattresses, wheelchair and seat cushions, positioning accessories, prophylactic or therapeutic advanced dressings, negative-pressure wound therapy systems used in pressure-ulcer care, and sensor-based systems that support repositioning or early intervention. Revenue includes equipment sales, rentals, consumables and market-specific service components where they form part of the device contract.

General hospital beds without a pressure-management function, ordinary household mattresses, pharmaceuticals, surgical procedures, nutritional products and routine nursing labor are excluded. This boundary prevents the market from being overstated by adjacent wound-care and hospital-furniture categories.

Growth Opportunities

Support Surfaces for Hospital and Long-Term Care Prevention

Pressure relief mattresses and specialty beds remain central to pressure injury prevention in hospitals, nursing homes and homecare. Buyers assess how well a support surface redistributes pressure, manages moisture and fits existing beds and care protocols.

Hospitals also weigh the cost of prevention against the clinical and financial consequences of hospital-acquired injuries. AHRQ reports that more than 2.5 million people in the United States develop pressure ulcers each year. This creates a continuing need for prevention programs and equipment suited to patients with different levels of mobility and risk.

Portable Seating Products for Patients Using Wheelchairs

Alternating pressure wheelchair cushions address pressure exposure during extended periods of seated mobility. Their portability and use in homecare and outpatient settings make them relevant to patients who need support outside a hospital bed.

Product design is moving toward battery-powered systems, alternating air cells and sensor-enabled features. Adoption depends on comfort, ease of use, maintenance requirements and whether patients and caregivers can operate the products consistently.

Advanced Dressings and Wound Management

Advanced wound dressings are used in both prevention and treatment. Products that manage moisture, protect vulnerable skin and support wound care can be incorporated into broader pressure injury protocols alongside repositioning, skin assessments and support surfaces.

For suppliers, the commercial opportunity depends on clinical evidence, product fit and integration into care routines. Hospitals and care facilities are likely to assess dressings as part of a full prevention and treatment pathway rather than as stand-alone products.

Pressure Ulcer Devices Market Key Takeaways

• Pressure relief mattresses held 30.81% of product revenue in 2025, supported by their use across hospitals, long-term care and homecare.
• North America represented 42.17% of global revenue in 2025. Its healthcare infrastructure and established medical-device purchasing base support the region’s lead.
• Asia-Pacific was the fastest-growing region, with a reported 8.7% CAGR. Aging populations, expanding healthcare capacity and homecare demand contribute to its growth outlook.
• Alternating pressure wheelchair cushions held 15.76% of revenue in 2025 and were identified as the fastest-growing product segment.
• Rising population aging expands the number of people at risk of reduced mobility. WHO projects that one in six people globally will be aged 60 or older by 2030.
• Emerging smart mattresses and sensor-enabled support surfaces still face an evidence gap. Providers need clinical and cost-effectiveness data before replacing established devices.
• Equipment suppliers compete on clinical performance, comfort, ease of use, service support and the ability to fit prevention protocols across multiple care settings.

Industry Trends and Strategic Insights

Care Providers Are Connecting Equipment Purchases to Injury Prevention

Pressure ulcer devices are increasingly selected as part of care programs that include risk assessment, repositioning, skin inspection and wound management. A mattress or cushion alone does not prevent every injury; performance depends on how the device fits patient needs and clinical routines.

In the United States, AHRQ’s prevention resources emphasize interdisciplinary approaches and systematic implementation. This places value on equipment that staff can use reliably and maintain within existing workflows.

Smart Surfaces Need Stronger Evidence to Expand Adoption

Sensor-enabled mattresses and overlays can provide pressure mapping or patient-position information. However, healthcare providers may hesitate to pay higher prices when evidence does not clearly show better outcomes or lower total costs than established support surfaces.

For manufacturers, clinical validation and economic evidence are important commercialization requirements. They can help hospital committees assess whether technology delivers measurable benefits in specific patient populations.

Homecare Is Increasing Demand for Portable Products

More care is taking place outside acute-care hospitals, increasing the importance of devices that patients and caregivers can use at home. Wheelchair cushions and portable support products must balance performance with manageable setup, maintenance and operating costs.

Products intended for home use face different purchasing conditions from hospital systems. Ease of use, caregiver training and dependable service become central to sustained adoption.

Prevention and Wound Treatment Remain Interconnected

Pressure ulcer management includes both prevention and treatment. Support surfaces, cushions and positioning systems help reduce pressure exposure, while dressings and negative pressure wound therapy can contribute to treatment plans for existing wounds.

This creates opportunities for suppliers with complementary product portfolios, though each product must be used according to its indication and clinical guidance.

Pressure Ulcer Devices Market Highlights

Disruption Analysis

From Passive Support to Connected Pressure Management

Traditional support surfaces redistribute pressure through foam, air, gel or hybrid materials. Newer products add sensors and monitoring features designed to help care teams identify patient positioning or pressure risks.

The shift creates a different purchasing question: whether the added monitoring produces useful clinical information and changes care decisions. Adoption will depend on evidence, integration into clinical routines and the cost of maintaining connected systems.

Care Delivery Is Spreading Beyond Hospitals

Homecare and outpatient settings are expanding the use of portable cushions and other pressure relief products. This changes product requirements: devices must be manageable for patients and caregivers, fit a variety of seating environments and have practical maintenance needs.

Manufacturers that design for both clinical and home use can serve a broader range of care pathways, but they must address different procurement channels and support expectations.

Market Dynamics

Growth Drivers

• Population aging: WHO projects that the number of people aged 60 or older will reach 1.4 billion by 2030, increasing demand for care suited to mobility limitations and chronic conditions.
• Immobility-related risk: Bedridden and wheelchair-dependent patients face prolonged pressure exposure, supporting demand for mattresses, cushions and specialty beds.
• Focus on prevention: Hospitals and long-term care providers use prevention programs to reduce pressure injuries and associated care burdens.
• Homecare expansion: Portable devices support pressure management outside hospitals and institutional care.
• Wound management needs: Advanced dressings and negative pressure systems support treatment of existing pressure ulcers.

Market Restraints

Limited Clinical Validation for New Technologies

Sensor-enabled mattresses and smart overlays may offer pressure monitoring or personalized support, but providers need robust clinical evidence to compare them with established alternatives. Without evidence of improved outcomes or cost-effectiveness, care facilities may defer adoption.

Upfront Cost and Reimbursement Constraints

Advanced mattresses, specialty beds and integrated wound therapy systems can require substantial initial investment. Smaller care facilities and homecare users may have limited budgets or inconsistent reimbursement coverage.

Workflow and Training Requirements

Devices must fit staff routines, patient handling practices and cleaning protocols. New equipment can require staff training and additional maintenance, affecting adoption where teams have limited time or technical resources.

Segmentation Analysis

By product type

Pressure-relief mattresses lead with a 30.81% share, equal to USD 1.35 billion when carried forward against the calculated 2025 market total. Their lead comes from broad use in hospitals, nursing facilities and homes, plus a product ladder extending from foam and gel surfaces to alternating-pressure and low-air-loss systems. Revenue is supported by replacement cycles, rental fleets, pumps, covers and service.

Alternating-pressure wheelchair cushions hold 15.76%, translating to USD 691.8 million on the same 2025 basis. The category is smaller than mattresses but benefits from demand outside the hospital, particularly among people with spinal cord injury, stroke-related disability, multiple sclerosis and long-duration mobility impairment. Pressure-relief cushions, specialty beds, accessories, advanced wound dressings and other technologies make up the balance. No separate published shares are available for those categories, so assigning precise percentages would create false precision.

By pressure-injury stage

Stage I and Stage II demand centers on prevention, early intervention, protective dressings, pressure redistribution and moisture control. Stage III and Stage IV care requires a more resource-intensive combination of specialty surfaces, advanced dressings, debridement support and, where clinically appropriate, negative-pressure wound therapy. The stage mix therefore influences revenue differently from patient count: severe injuries are less common but use more devices, consumables and clinical time per case.

By end user

Hospitals form the principal end-user group because intensive care, surgery, emergency holding and immobility concentrate risk. Nursing homes require durable surfaces and simple protocols that can operate under persistent staffing pressure. Home care increasingly uses overlays, compact alternating-pressure mattresses and wheelchair cushions after discharge. Specialty clinics participate mainly through wound assessment, dressing selection and advanced therapy management. Published end-user percentages are not available on the source page; the report should retain the ranking without fabricating shares.

Regional and Country Analysis

North America: 42.17% Share

North America held 42.17% of the global market in 2025, equivalent to USD 1.85 billion when applied to the 2025 total. The United States anchors the region through its hospital base, nursing-facility network, reimbursement pressure and presence of major suppliers. AHRQ’s figure of more than 2.5 million U.S. pressure-ulcer cases each year provides a direct measure of clinical need. CMS adds a financial lever: hospitals in the worst-performing quartile under the HAC Reduction Program lose 1% of Medicare fee-for-service payments. The strongest demand is consequently moving toward prevention systems that combine support surfaces with verifiable turning compliance and outcome reporting.

United States

The United States is a major market for pressure ulcer prevention and treatment devices. AHRQ reports that more than 2.5 million people develop pressure ulcers in the country each year. Its prevention resources also note that hospitals do not receive additional reimbursement for treating pressure ulcers acquired during a hospital stay, reinforcing the economic importance of prevention.

U.S. providers use support surfaces, cushions, wound dressings and negative pressure systems across acute, post-acute and homecare environments. Procurement decisions depend on patient risk, evidence of performance, ease of use and reimbursement or budget constraints.

Asia-Pacific: Fastest-Growing Region

Asia-Pacific carries the fastest published regional CAGR at 8.7%. Japan’s age structure makes prevention central to acute and long-term care: official population estimates continue to place the country among the world’s most aged societies, increasing exposure to immobility, frailty and post-surgical recovery. Products that fit compact rooms, operate quietly and can be cleaned quickly have a practical advantage across Japanese hospitals and care homes.

South Korea entered a super-aged demographic structure when people aged 65 and older exceeded one-fifth of the resident population. Hospital digitization and a concentrated urban care network support connected monitoring, but local evidence, reimbursement fit and Korean-language training remain necessary for adoption. Across both countries, compact alternating-pressure systems and sensor-assisted repositioning are positioned more strongly than heavy equipment designed only for large acute-care rooms

China

China’s aging population and expanding healthcare capacity support demand for support surfaces, wound-care products and pressure relief systems. Adoption varies between large urban hospitals, long-term care institutions and homecare settings, where access and purchasing power differ.

Japan

Japan’s aging population and established medical-care system support interest in pressure injury prevention and care for patients with limited mobility. Demand spans hospitals, nursing homes and homecare providers.

India

India’s market is influenced by expanding hospital infrastructure, a large population requiring chronic and post-acute care, and the growth of homecare services. Price sensitivity and uneven access to specialized equipment affect product selection.

The source page does not publish country-level revenue shares for China, Japan or India; country discussion is therefore qualitative.

Europe

Europe’s market is supported by an aging population, established healthcare systems and use of advanced wound-care and support-surface products. The source page notes that people aged 65 or older make up more than 20% of the region’s population.

Germany, France and the United Kingdom are cited as leading markets because of their healthcare infrastructure and adoption of pressure injury prevention and treatment technologies.

South America, Middle East and Africa

South America, the Middle East and Africa are included in the market scope. Demand is linked to healthcare infrastructure, availability of wound-care services and access to support surfaces in hospitals and long-term care. The source does not provide quantified regional shares or country revenue values for these markets.

Competitive Landscape

Competition is shaped by clinical performance, product range, patient comfort, ease of cleaning, device durability, service coverage and clinical evidence. Suppliers compete across support surfaces, beds, cushions, dressings and wound therapy systems.

Key Players

• Stryker Corporation
• Baxter (Hill-Rom Holdings, Inc.)
• 3M Company
• ArjoHuntleigh
• Mölnlycke Health Care
• ConvaTec
• Coloplast Group
• Smith+Nephew
• Medline Industries
• Paul Hartmann AG
• Essity AB
• BSN Medical GmbH
• Medtronic plc
• B. Braun Melsungen AG
• Cardinal Health, Inc.
• Paramount Bed Holdings Co. Ltd.
• Apex Medical Corp.
• DARCO International
• DeRoyal Industries
• Talley Group Limited
• LINET

Examples of established product offerings include Stryker’s IsoAir support surface, Arjo’s Nimbus mattress systems and Mölnlycke’s Mepilex dressings. These products address different parts of pressure injury prevention and wound care, from pressure redistribution to skin protection and dressing management.

Company Profiles

Stryker

Stryker competes through a broad support-surface portfolio covering beds, stretchers and patient-transfer environments. Relevant products include IsoAir powered therapy, Isolibrium for critical care, IsoTour gel surfaces, IsoFlex SE stretcher surfaces, ProForm, ComfortGel and SofCare cushions and overlays. This range lets hospitals standardize pressure-management specifications across multiple departments. The strategic advantage is workflow coverage: preventing pressure exposure during transport and emergency holding closes gaps that mattress-only contracts leave unresolved. Stryker’s global scale and established acute-care relationships support installation, service and integration with bed fleets.

Arjo

Arjo combines pressure-injury prevention with patient handling, medical beds and mobility solutions. Its portfolio includes Auralis Plus, Nimbus 4, AtmosAir Velaris, Alpha Active systems, TheraKair Visio and Skin IQ microclimate products. The company reported around SEK 11 billion in 2025 turnover and sells in more than 100 countries. Its competitive position rests on linking pressure redistribution with repositioning and safe mobility. This is clinically relevant because a surface cannot replace movement; equipment, slings and staff workflow must function together.

Smith+Nephew

Smith+Nephew addresses the market through advanced dressings, negative-pressure wound therapy and digital prevention. The 2026 launches of ALLEVYN COMPLETE CARE, RENASYS EDGE and next-generation LEAF create a connected portfolio spanning skin protection, wound management and repositioning compliance. Group revenue reached USD 6.16 billion in 2025, up 6.1% on a reported basis. More than 60% of the company’s 2025 underlying revenue growth came from products launched within the previous five years. Its commercial differentiator is the ability to sell prevention and treatment across the same hospital pathway rather than treating them as separate budgets.

Convatec

Convatec supplies advanced foam, antimicrobial and other dressings for acute and chronic wounds. Its wound-care portfolio, including ConvaFoam and AQUACEL technologies, gives the company recurring consumables exposure after a pressure injury appears or when prophylactic protection is indicated. Convatec operates in around 90 countries with more than 10,000 employees. The 2026 UK manufacturing expansion of more than GBP 24 million strengthens capacity and supply continuity. Its opportunity is to convert clinical familiarity with dressings into standardized protocols across hospitals, community care and home treatment.

Procurement and Technology Evaluation Criteria

A complete product evaluation should cover pressure redistribution, shear reduction, microclimate control, heel-zone performance, weight capacity, pump noise, backup operation, cover durability, cleaning time and compatibility with infection-control chemicals. Connected products add EMR integration, data ownership, cybersecurity, alert configuration and dashboard usability. Contract analysis should compare purchase, rental and managed-service models over the expected utilization period, including pump replacement, cover damage, preventive maintenance and downtime.

Clinical validation must match the intended setting. Evidence from an intensive-care population does not automatically establish performance in long-term care or home use. Suppliers should present outcome definitions, comparator surfaces, patient risk levels and adherence assumptions. A lower-cost device that staff use correctly can outperform a premium system that complicates transfers or creates alarm fatigue.

Recent Developments

• April 21, 2026 - Convatec: The company presented its advanced wound-care innovation at EWMA 2026. The program reinforced the role of advanced dressings in chronic-wound pathways, including wounds requiring exudate control and protection from further tissue damage.
• May 5, 2026 - Smith+Nephew: ALLEVYN COMPLETE CARE and RENASYS EDGE were presented for European launch. ALLEVYN COMPLETE CARE uses five layers, an exudate-change indicator and a shear-dissipating layer; company testing states that the dressing releases up to 100 times fewer bacteria than comparator foam dressings. RENASYS EDGE reported average therapy-session compliance of 88% in the evidence cited by the manufacturer.
• June 1, 2026 - Smith+Nephew: The next-generation LEAF Patient Monitoring System launched in the United States. Its wearable sensor records mobility and turn status, while the cloud-hosted platform integrates with electronic medical records. This development moves pressure-injury prevention from scheduled manual checks toward documented, exception-based workflows.
• July 3, 2026 - Convatec: The company completed a more than GBP 24 million expansion of its UK advanced wound-care manufacturing site. The investment increases supply resilience for dressings used across chronic and acute wound pathways.
• August 4, 2026 - Convatec: First-half 2026 results confirmed continued investment across Advanced Wound Care and the wider chronic-care portfolio. Convatec operates in around 90 countries with more than 10,000 employees, giving the business a broad platform for scaling new foam and antimicrobial dressing technologies.
• August 2026 - Stryker: The company updated its IsoFlex SE support-surface documentation. The surface addresses pressure and shear on stretchers, drawing attention to a procurement gap often missed in prevention programs: patients remain exposed during emergency-department holding, imaging, transport and perioperative transfer, not only while occupying an inpatient bed.

Market Scope

The global pressure ulcer devices market report delivers a detailed analysis with 56 key tables, more than 57 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Suggestions for Related Report

• Venous Leg Ulcers Treatment Market

For more medical devices-related reports, please click here